RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

BACKGROUND: Despite obvious advances over the last decades, locally advanced adenocarcinomas of the gastroesophageal junction (GEJ) still carry a dismal prognosis with overall 5-year survival rates of less than 50% even when using modern optimized treatment protocols such as perioperative chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzen, Sylvie, Biederstädt, Alexander, Ronellenfitsch, Ulrich, Reißfelder, Christoph, Mönig, Stefan, Wenz, Frederik, Pauligk, Claudia, Walker, Martin, Al-Batran, Salah-Eddin, Haller, Bernhard, Hofheinz, Ralf-Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493344/
https://www.ncbi.nlm.nih.gov/pubmed/32933498
http://dx.doi.org/10.1186/s12885-020-07388-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493344/
https://www.ncbi.nlm.nih.gov/pubmed/32933498
http://dx.doi.org/10.1186/s12885-020-07388-x

Ejemplares similares